-
Emergency
-
Apollo Lifeline
-
Emergency
Morning Slots
AFTERNOON Slots
Dr Bopaiah K S
Neurosurgery
9+ Years Experience
DNB
Apollo Bgs Hospitals Mysore
English
Mon - Sun
10:00 -10:30
Dr Bopaiah K S
Neurosurgery
9+ Years Experience
DNB
Apollo Bgs Hospitals Mysore
English
Mon - Sun
10:00 -10:30
Description
Dr. Bopaiah S is a prominent Neurosurgeon based in Mysore, Karnataka, with an impressive clinical experience of 9 years. As a member of the Apollo group, Dr. Bopaiah specializes in the intricate and delicate field of neurosurgery, which involves the diagnosis and treatment of conditions affecting the brain, spinal cord, and nervous system. His expertise covers a wide range of neurosurgical procedures, allowing him to provide comprehensive care to his patients. Fluent in English, Dr. Bopaiah ensures effective communication with his patients, helping them understand their treatment options and fostering a trusting doctor-patient relationship. His professional journey is marked by a commitment to excellence, and he is dedicated to improving the lives of his patients through advanced surgical techniques and personalized care. Whether handling complex surgeries or providing essential pre- and post-operative care, Dr. Bopaiah focuses on delivering positive outcomes and enhancing the overall health and well-being of those he treats. His practice is enriched by a strong educational background, holding a DNB qualification, which reflects his dedication to staying current with the latest advancements in neurosurgery. Patients seeking expert neurosurgical care in Mysore can confidently rely on Dr. Bopaiah S for his professionalism, skill, and unwavering commitment to their health.
Experience
- Headed the Dept of Neurosurgery, OPEC Hospital,Raichur (150 bedded Superspecialty hospital jointly managed by Govtof Karnataka and Apollo Hospitals Group).
- Consultant Neurosurgeon at Apollo BGS Hospital since Aug- 2011.
Special Interests
- Microneurosurgery, VascularNeurosurgery – Aneurysm / AVM, Brain / Spinal Tumors, Paediatric Neurosurgery, Neuro-endoscopy, Trauma
Awards & Achievements
Best Doctor Award 2019 by TamilNadu Government
Research & Publication
- R.R Ravi, K S Bopaiah, et al. Ravi Rectangle. J. Spinal Surg 2010; 2(2): 415-17 Effects of tranexamic acid on death, vascular occlusive events, and blood transfusion in trauma patients with significant haemorrhage (CRASH-2): a randomised, placebo-controlled trial, Lancet Online, June 15,2010, DOI:10.1016/S0140-6736(10)60835-5. Predicting outcome after traumatic brain injury: practical prognostic models based on large cohort of international patients-BMJ, Feb 2008; 336: 425 - 429. Final results of MRC CRASH, a randomized placebo-controlled trial of intravenous corticosteroid in adults with head injury- Outcome at 6months.
- Lancet 2005; 365:1957-59. Effect of intravenous corticosteroid on death within 14 days in 10008 adults with clinically significant head injury: Randomized placebo-controlled trial. Lancet 2004; 364:1321-28. Update on progress in the international, multicenter, randomized, controlled trial of corticosteroids after significant head injury (Medical Research Council CRASH Trial) - Current Opinion in Critical Care. 9(2):92-97, April 2003.
- Phase II Project – A prospective study to correlate gene signatures with clinical outcome of Astrocytomas and identification of potential targets at NIMHANS under Council of Scientific & Industrial Research (CSIR), New Delhi. BRAIN TRIAL – Bradykinin beta 2 Receptor Antagonist InNeurotrauma Phase II randomized double blind placebo controlled dose finding safety & tolerability trial of XY2405 (Bradykinin beta 2 Receptor Antagonist) as a treatment for Traumatic brain injury.
- CRASH 2 – (Clinical Randomization of an Anti-fibrinolytic in Significant Hemorrhage) Randomized placebo controlled trial of the effect of early transfusion of Tranexamic Acid on death & transfusionrequirement in patients with significant hemorrhage or at risk of significant hemorrhage. CRASH 1 – (Corticosteroid Randomization AfterSignificant Head injury) Randomized placebo controlled trial among adults with head injury and impaired consciousness, of the effects of a 48 hour infusion of corticosteroids on death and neurological disability.
